Medpace Holdings Inc vs Wix.Com Ltd — how do they compare? Medpace Holdings Inc trades at $528.29 (market cap $15.08B), while Wix.Com Ltd trades at $52.56 (market cap $2.23B). The key difference: Medpace Holdings Inc is far larger — about 6.8× Wix.Com Ltd's market cap, and Medpace Holdings Inc is trading nearer its 52-week high, Wix.Com Ltd nearer its low. Which is the better fit depends on your goals.
| MEDP | WIX | |
|---|---|---|
Market Cap | $15.08B | $2.23B |
Sector | Technology | Technology |
52-Week High | $620.59 | $184.24 |
52-Week Low | $308.88 | $40.43 |
Enterprise Value | $14.55B | $1.80B |
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $527.93, down 1.82% today, with a bullish technical outlook supported by moving averages. The company demonstrates strong profitability with 17.19% net margins and 77.25% ROE, though valuation ratios appear elevated with a P/E of 33.83. Recent earnings have consistently beaten expectations, and cash flow is projected to improve significantly in 2026. However, the stock faces headwinds from ongoing class action lawsuits and mixed analyst sentiment with 73.69% hold ratings.
MEDP presents a mixed investment case with strong fundamental performance offset by legal overhangs and premium valuation. The company's consistent earnings beats and projected cash flow improvement support upside potential, but investors should weigh the legal risks and cautious analyst stance against the robust operational metrics.
Wix trades at $53.34, up 3.67% on the day, with a bearish technical signal and mixed fundamentals. Revenue grew to $1.99B in 2025, but net income fell to $50.65M with a negative margin of -1.97%. The stock faces headwinds from recent earnings misses and legal investigations, yet maintains strong analyst support with a consensus price target of $83.07.
The outlook is cautious due to high valuation multiples and operational risks, but long-term growth potential exists if Wix can leverage AI tools and partnerships to improve profitability. Key risks include competitive pressure and ongoing legal scrutiny, while institutional sentiment remains predominantly bullish.
Trailing returns across standard periods
Latest headlines on both assets
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →Wix.com Ltd is a cloud-based development platform provider for millions of registered users worldwide. The company is engaged in web development and management that provides an easy-to-use powerful cloud-based platform of products through a freemium model. Its core products consist of three web editors: the Wix Editor, intended for users with basic technological skills, Wix ADI, intended for novice users and Corvid, intended for more tech-savvy users. The company's web development technology is built based on HTML5 and offers HTML5 compatible capabilities, web design and layout tools, domain hosting, and other marketing and workflow management applications and services. The geographic segments include North America, Europe, Latin America, Asia and others.
Read more on WIX →